Skip to main content
Clinical Trials/ACTRN12606000290594
ACTRN12606000290594
Completed
Phase 3

A randomised controlled trial of therapeutic lung lavage to reduce the duration of respiratory support required by ventilated newborn infants with meconium aspiration syndrome (MAS)

A/Prof Peter Dargaville0 sites66 target enrollmentOctober 25, 2004

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Meconium aspiration syndrome
Sponsor
A/Prof Peter Dargaville
Enrollment
66
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 25, 2004
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
A/Prof Peter Dargaville

Eligibility Criteria

Inclusion Criteria

  • Neonates (males and females)with confirmed diagnosis of meconium aspiration syndrome with all of the following:1\. birth weight \>2\.0kgs, gestation \>36 weeks.2\. \<24 hours of age3\. ventilated with mean airway pressure \>/\= 12 cm H2O4\. Alveolar\-arterial oxygen difference \>/\= 450 mmHg

Exclusion Criteria

  • Known or suspected cardiac abnormality. Severe hypoxic ischaemic encephalopathy or congenital anomaly (ie, withdrawal of treatment being considered). Intractable cardiorespiratory instability.

Outcomes

Primary Outcomes

Not specified

Similar Trials